A detailed history of E Fund Management Co., Ltd. transactions in Moderna, Inc. stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 10,694 shares of MRNA stock, worth $1.27 Million. This represents 0.07% of its overall portfolio holdings.

Number of Shares
10,694
Previous 12,298 13.04%
Holding current value
$1.27 Million
Previous $1.22 Million 6.87%
% of portfolio
0.07%
Previous 0.08%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024

SELL
$85.37 - $115.44 $136,933 - $185,165
-1,604 Reduced 13.04%
10,694 $1.14 Million
Q4 2023

Feb 06, 2024

BUY
$69.51 - $104.43 $216,940 - $325,926
3,121 Added 34.01%
12,298 $1.22 Million
Q3 2023

Nov 13, 2023

BUY
$96.41 - $126.61 $134,588 - $176,747
1,396 Added 17.94%
9,177 $948,000
Q2 2023

Aug 11, 2023

BUY
$118.5 - $160.53 $27,847 - $37,724
235 Added 3.11%
7,781 $945,000
Q1 2023

May 11, 2023

BUY
$135.66 - $197.02 $36,356 - $52,801
268 Added 3.68%
7,546 $1.16 Million
Q4 2022

Feb 14, 2023

SELL
$118.38 - $210.04 $196,747 - $349,086
-1,662 Reduced 18.59%
7,278 $1.31 Million
Q3 2022

Nov 14, 2022

BUY
$118.07 - $194.18 $27,982 - $46,020
237 Added 2.72%
8,940 $1.06 Million
Q2 2022

Aug 15, 2022

BUY
$117.13 - $176.59 $176,046 - $265,414
1,503 Added 20.88%
8,703 $1.24 Million
Q1 2022

May 12, 2022

BUY
$126.46 - $235.05 $186,781 - $347,168
1,477 Added 25.81%
7,200 $1.24 Million
Q4 2021

Feb 11, 2022

BUY
$225.82 - $368.51 $117,200 - $191,256
519 Added 9.97%
5,723 $1.45 Million
Q3 2021

Nov 12, 2021

BUY
$221.9 - $484.47 $35,060 - $76,546
158 Added 3.13%
5,204 $2 Million
Q1 2021

May 12, 2021

BUY
$109.18 - $185.98 $550,922 - $938,455
5,046 New
5,046 $660,000

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $46.3B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track E Fund Management Co., Ltd. Portfolio

Follow E Fund Management Co., Ltd. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.